Choosing the best second-line tyrosine kinase inhibitor in imatinib-resistant chronic myeloid leukemia patients harboring Bcr-Abl kinase domain mutations: how reliable is the IC₅₀?
| Image |  |
|---|---|
| Description | scientific article published on 31 May 2011 |
| Author/s |
author: Gianantonio Rosti Michele Baccarani Giovanni Martinelli Simona Soverini Ilaria Iacobucci |
| Publication date | May 31, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |